TGFB1 and cancer: It has also been observed that exosomes derived from CAFs containing TGF-β activate the SMAD signaling pathway in cancer cells through a particular type of epithelial-mesenchymal transition (EMT), which increases their malignant behavior (Li et al., 2017), thus generating a loop between CAFs and exosomes.